CSTL R&D to Revenue
Castle Biosciences Inc · R&D to Revenue
CSTL R&D to Revenue
Latest reported15.06%period ending
CSTL FY R&D/Revenue (32.52% → 15.06%)
Latest values, visible window
High-resolution chart · PNG
CSTL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.0626% | |
| 15.6717% | |
| 24.3953% | |
| 32.7666% | |
| 31.5098% | |
| 21.1592% | |
| 14.2389% | |
| 21.3038% | |
| 32.5226% |